We are live on ! Find out more
CL

Choreo LLC Portfolio holdings

AUM $8.15B
1-Year Est. Return 20.12%
This Fund
S&P 500
This Quarter Est. Return
+2.42%
1 Year Est. Return
+20.12%
3 Year Est. Return
+59.68%
5 Year Est. Return
+57.89%
10 Year Est. Return
+205.42%
AUM
$5.96B
AUM Growth
+$2.07B
Cap. Flow
+$2B
Cap. Flow %
33.48%
Top 10 Hldgs %
30.72%
Holding
1,529
New
864
Increased
570
Reduced
53
Closed
13

Top Buys

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$95.8M
2
AAPL icon
Apple
AAPL
+$77.1M
3
MSFT icon
Microsoft
MSFT
+$70.4M
4
NVDA icon
NVIDIA
NVDA
+$50.7M
5
AMZN icon
Amazon
AMZN
+$42.9M

Sector Composition

Rank Sector Weight
1 Technology 12.62%
2 Financials 8.07%
3 Consumer Discretionary 4.51%
4 Healthcare 4.05%
5 Industrials 3.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LFST icon
1376
Lifestance Health
LFST
$4.16B
$134K ﹤0.01%
+26,850
New +$162K
BGR icon
1377
BlackRock Energy and Resources Trust
BGR
$421M
$133K ﹤0.01%
10,045
CKPT
1378
DELISTED
Checkpoint Therapeutics
CKPT
$133K ﹤0.01%
65,002
+7,080
+12% +$12.6K
KW
1379
DELISTED
Kennedy-Wilson Holdings
KW
$133K ﹤0.01%
+13,625
New +$127K
SUZ icon
1380
Suzano
SUZ
$10.2B
$128K ﹤0.01%
+12,559
New +$132K
CLM icon
1381
Cornerstone Strategic Value Fund
CLM
$2.18B
$125K ﹤0.01%
+16,435
New +$122K
PLTK icon
1382
Playtika
PLTK
$1.4B
$124K ﹤0.01%
+16,187
New +$128K
BCX icon
1383
BlackRock Resources & Commodities Strategy Trust
BCX
$900M
$123K ﹤0.01%
+13,349
New +$123K
EXK
1384
Endeavour Silver
EXK
$2.31B
$122K ﹤0.01%
+35,102
New +$114K
IOVA icon
1385
Iovance Biotherapeutics
IOVA
$2.24B
$116K ﹤0.01%
+14,354
New +$154K
GRAB icon
1386
Grab
GRAB
$13.5B
$112K ﹤0.01%
+31,768
New +$112K
NIO icon
1387
NIO
NIO
$11.3B
$112K ﹤0.01%
25,255
+2,313
+10% +$10.9K
CFFN icon
1388
Capitol Federal Financial
CFFN
$1.08B
$111K ﹤0.01%
+20,347
New +$106K
GNW icon
1389
Genworth Financial
GNW
$3.81B
$110K ﹤0.01%
+18,229
New +$113K
PCF
1390
High Income Securities Fund
PCF
$100M
$110K ﹤0.01%
+15,941
New +$105K
HOPE icon
1391
Hope Bancorp
HOPE
$1.73B
$108K ﹤0.01%
+10,166
New +$107K
UMC icon
1392
United Microelectronic
UMC
$48.6B
$106K ﹤0.01%
+12,129
New +$100K
CRK icon
1393
Comstock Resources
CRK
$4.01B
$105K ﹤0.01%
+10,247
New +$107K
PARA
1394
DELISTED
Paramount Global Class B
PARA
$104K ﹤0.01%
+10,198
New +$119K
EARN
1395
Ellington Residential Mortgage REIT
EARN
$166M
$103K ﹤0.01%
15,087
+488
+3% +$3.38K
AMCR icon
1396
Amcor
AMCR
$20.4B
$103K ﹤0.01%
+2,134
New +$104K
BDN
1397
Brandywine Realty Trust
BDN
$554M
$103K ﹤0.01%
+23,295
New +$106K
TEF
1398
DELISTED
Telefonica
TEF
$102K ﹤0.01%
+24,030
New +$106K
SOFI icon
1399
SoFi Technologies
SOFI
$21.1B
$101K ﹤0.01%
+15,750
New +$111K
FIP icon
1400
FTAI Infrastructure
FIP
$507M
$99.5K ﹤0.01%
+11,452
New +$87.3K

Similar funds

Choreo LLC's Q2 2024 Portfolio in Review

As of Q2 2024, Choreo LLC held 1,529 positions worth $5.96B, up 53% from $3.89B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Choreo LLC deployed $2B of net new capital in Q2 2024, opening 864 new positions and adding to 570 existing holdings. Its largest new stake was Blackstone Mortgage Trust: 407,643 shares worth $6.98M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 7.6% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Small-Cap Value ETF, an estimated $6.41M trimmed.

  • Choreo LLC's largest Q2 2024 buy was Blackstone Mortgage Trust: 407,643 shares worth $6.98M.
  • Choreo LLC added most to Bank of America in Q2 2024, an estimated $95.8M increase.
  • Choreo LLC's biggest Q2 2024 reduction was Vanguard Small-Cap Value ETF, cutting an estimated $6.41M.
  • Choreo LLC fully exited Fulton Financial in Q2 2024, selling an estimated $268K.
  • Choreo LLC's ten largest holdings make up 31% of its $5.96B portfolio in Q2 2024.
  • Choreo LLC opened 864 new positions and closed 13 in Q2 2024.
  • Choreo LLC's portfolio value rose 53% quarter-over-quarter to $5.96B.

Based on Choreo LLC's 13F filing for Q2 2024, filed 7 Aug 2024.